Z Gastroenterol 2011; 49(9): 1263-1266
DOI: 10.1055/s-0029-1245981
Kasuistik

© Georg Thieme Verlag KG Stuttgart · New York

Acute Pancreatitis in a Patient with Hypercalcemia due to Tertiary Hyperparathyroidism

Akute Pankreatitis bei einem Patienten mit Hypercalcämie infolge eines tertiären HyperparathyreoidismusJ. Stephani1 , A. S. Akinli1 , G. von Figura1 , T. F. E. Barth2 , T. Weber3 , B. Hartmann1 , G. Adler1 , G. B. von Boyen1
  • 1Department of Internal Medicine I, University of Ulm, Germany
  • 2Department of Pathology, University of Ulm, Germany
  • 3Department of General, Visceral, and Transplantation Surgery, University of Ulm, Germany
Further Information

Publication History

manuscript received: 22.9.2010

manuscript accepted: 17.12.2010

Publication Date:
01 September 2011 (online)

Zusammenfassung

Hypercalcämie gilt als unabhängiger Risikofaktor für die akute Pankreatitis und wird häufig durch eine Nebenschilddrüsenüberfunktion verursacht. In dieser Kasuistik berichten wir über einen 35-jährigen Patienten, der sich 6 Wochen nach Nierentransplantation mit abdominellen Schmerzen in unserer Klinik vorstellte. Mittels Laboranalytik und Ultraschalldiagnostik wurde eine akute Pankreatitis mit Hypercalcämie auf dem Boden eines tertiären Hyperparathyreoidismus diagnostiziert. Nach konservativer Therapie der akuten Pankreatitis erfolgte eine Parathyreoidektomie mit autologer Gewebetransplantation. Dieser Fallbericht präsentiert die akute Pankreatitis als schwerwiegende und außergewöhnliche Komplikation eines tertiären Hyperparathyreoidismus nach Nierentransplantation.

Abstract

Hypercalcemia represents an independent risk factor of acute pancreatitis and can result from hyperfunctioning parathyroid glands. Here, we report on a 35-year-old patient who was admitted to our hospital with abdominal pain six weeks after kidney transplantation. Based on laboratory tests and ultrasound imaging, acute pancreatitis with hypercalcemia due to tertiary hyperparathyroidism was diagnosed. Subsequently, the patient was treated by parathyroidectomy with autologous tissue transplantation. This constellation points to acute pancreatitis as a very rare and severe complication of patients developing tertiary hyperparathyroidism-related hypercalcemia from secondary hyperparathyroidism after kidney transplantation.

References

  • 1 Weber C K, Adler G. Acute pancreatitis.  Curr Opin Gastroenterol. 2003;  19 447-450
  • 2 Carnaille B, Oudar C, Pattou F et al. Pancreatitis and primary hyperparathyroidism: forty cases.  Aust N Z J Surg. 1998;  68 117-119
  • 3 Agarwal A, George R K, Gupta S K et al. Pancreatitis in patients with primary hyperparathyroidism.  Indian J Gastroenterol. 2003;  22 224-225
  • 4 Goar W S. Case records of Massachusetts General Hospital.  New Engl J Med. 1963;  268 943
  • 5 Kilgo M S, Pirsch J D, Warner T F et al. Tertiary hyperparathyroidism after renal transplantation: surgical strategy.  Surgery. 1998;  124 677-683 ; discussion 683–684
  • 6 Arnold A, Brown M F, Urena P et al. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia.  J Clin Invest. 1995;  95 2047-2053
  • 7 Buchwald P C, Akerstrom G, Westin G. Reduced p18INK4c, p21CIP1 /WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism.  Clin Endocrinol. 2004;  60 389-393
  • 8 Imanishi Y, Tahara H, Palanisamy N et al. Clonal chromosomal defects in the molecular pathogenesis of refractory hyperparathyroidism of uremia.  J Am Soc Nephrol. 2002;  13 1490-1498
  • 9 Lankisch P G, Assmus C, Maisonneuve P et al. Epidemiology of pancreatic diseases in Luneburg County. A study in a defined german population.  Pancreatology. 2002;  2 469-477
  • 10 Felderbauer P, Karakas E, Fendrich V et al. Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene.  Am J Gastroenterol. 2008;  103 368-374
  • 11 Krims P E, Pandol S J. Free cytosolic calcium and secretagogue-stimulated initial pancreatic exocrine secretion.  Pancreas. 1988;  3 383-390
  • 12 Frick T W, Mithofer K, Fernandez-del Castillo C et al. Hypercalcemia causes acute pancreatitis by pancreatic secretory block, intracellular zymogen accumulation, and acinar cell injury.  Am J Surg. 1995;  169 167-172
  • 13 Dooley M A, Cosio F G, Nachman P H et al. Mycophenolate mofetil therapy in lupus nephritis: clinical observations.  J Am Soc Nephrol. 1999;  10 833-839
  • 14 D’Alessandro A M, Melzer J S, Pirsch J D et al. Tertiary hyperparathyroidism after renal transplantation: operative indications.  Surgery. 1989;  106 1049-1055 ; discussion 1055–1036
  • 15 Triponez F, Clark O H, Vanrenthergem Y et al. Surgical treatment of persistent hyperparathyroidism after renal transplantation.  Ann Surg. 2008;  248 18-30
  • 16 Rothmund M, Wagner P K, Schark C. Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial.  World J Surg. 1991;  15 745-750
  • 17 Weber T, Zeier M, Hinz U et al. Impact of intraoperative parathyroid hormone levels on surgical results in patients with renal hyperparathyroidism.  World J Surg. 2005;  29 1176-1179
  • 18 Lewin E, Olgaard K. Parathyroidectomy vs calcimimetics for treatment of persistent hyperparathyroidism after kidney transplantation.  Nephrol Dial Transplant. 2006;  21 1766-1769

Johannes Stephani, MD

Department of Internal Medicine I, University of Ulm

Albert-Einstein-Allee 23

89081 Ulm

Germany

Phone: ++ 49/7 31/50 04 47 18

Fax: ++ 49/7 31/50 04 45 02

Email: johannes.stephani@uniklinik-ulm.de

    >